A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML-Reference-Cited by-同舟云学术

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

Published:2023-11-07 Issue:1 Volume:38 Page:58-66
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Garcia-Manero Guillermo^ORCID,Podoltsev Nikolai A.^ORCID,Othus Megan^ORCID,Pagel John M.^ORCID,Radich Jerald P.,Fang Min,Rizzieri David A.^ORCID,Marcucci Guido^ORCID,Strickland Stephen A.^ORCID,Litzow Mark R.^ORCID,Savoie M. Lynn,Medeiros Bruno C.,Sekeres Mikkael A.^ORCID,Lin Tara L.^ORCID,Uy Geoffrey L.^ORCID,Powell Bayard L.,Kolitz Jonathan E.,Larson Richard A.,Stone Richard M.,Claxton David^ORCID,Essell James,Luger Selina M.,Mohan Sanjay R.,Moseley Anna^ORCID,Appelbaum Frederick R.,Erba Harry P.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-023-02073-x.pdf

Reference19 articles.

1. Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N. Engl J Med. 2015;373:1136–52.

2. Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N. Engl J Med. 2012;366:1079–89.

3. Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77.

4. Dinardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, et al. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N. Engl J Med. 2020;383:617–29.

5. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N. Engl J Med. 1994;331:896–903.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular precision medicine: Multi-omics-based stratification model for acute myeloid leukemia;Heliyon;2024-09

2. Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203;Leukemia;2024-06-03

3. Medium-cumulative dose of cytarabine in consolidation therapy shows the greatest benefit in AML patients;Holistic Integrative Oncology;2024-05-21

4. AML treatment: conventional chemotherapy and emerging novel agents;Trends in Pharmacological Sciences;2024-05

5. Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203;2024-03-11